European Union · Question · QUESTION_WRITTEN
E-9-2022-000465
Access for European Union citizens to the most modern methods of treatment of spinal muscular atrophy (SMA)
Introduced
3 February 2022
Last action
—
Status
answered
Sponsors
—
Subjects
Discovery layer
Source updated
1 April 2022
Records
Official question E-9-2022-000465 from European Union at European Parliament. Dated 3 February 2022. Status: answered.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
7 official files
EU citizens’ access to state-of-the-art treatments for spinal muscular atrophy (SMA)
EU citizens’ access to state-of-the-art treatments for spinal muscular atrophy (SMA)
QUESTION_WRITTEN · EN · 16 February 2022
EU citizens’ access to state-of-the-art treatments for spinal muscular atrophy (SMA)
QUESTION_WRITTEN · EN · 16 February 2022
EU citizens’ access to state-of-the-art treatments for spinal muscular atrophy (SMA)
QUESTION_WRITTEN · EN · 16 February 2022
Answer
QUESTION_WRITTEN_ANSWER · 1 April 2022
Dostęp obywateli Unii Europejskiej do najnowocześniejszych metod leczenia rdzeniowego zaniku mięśni (ang. spinal muscular atrophy, SMA)
QUESTION_WRITTEN · PL · 16 February 2022
Dostęp obywateli Unii Europejskiej do najnowocześniejszych metod leczenia rdzeniowego zaniku mięśni (ang. spinal muscular atrophy, SMA)
QUESTION_WRITTEN · PL · 16 February 2022
Dostęp obywateli Unii Europejskiej do najnowocześniejszych metod leczenia rdzeniowego zaniku mięśni (ang. spinal muscular atrophy, SMA)
QUESTION_WRITTEN · PL · 16 February 2022
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.